Details of the Drug
General Information of Drug (ID: DMH17MU)
Drug Name |
Gabaculine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
DL-Gabaculine; 3-Amino-2,3-dihydrobenzoic acid; GABACULINE, D.L-; Gabaculin; 59556-18-2; 5-Amino-1,3-cyclohexadienylcarboxylic acid; 5-aminocyclohexa-1,3-diene-1-carboxylic acid; NSC-329502; 87980-11-8; C7H9NO2; (+-)-Gabaculine; AC1L1FYB; AC1Q5RCE; Biomol-NT_000232; Lopac0_000006; SCHEMBL2024044; BPBio1_000639; CHEMBL1394922; CTK1H1588; DTXSID90274399; KFNRJXCQEJIBER-UHFFFAOYSA-N; CPD0-1467; NSC329502; Benzoic acid, 3-amino-2,3-dihydro-; NSC 329502; CCG-204102; NCGC00015051-04; NCGC00015051-03; NCGC00162040-01; NCGC00015051-02
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 139.15 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -2.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||